First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation.
- Published Article
The Thoracic and cardiovascular surgeon
- Publication Date
Jun 01, 2004
We conclude that transplant patients with impaired kidney function will have an immediate benefit from partially replacing calcineurin inhibitors by rapamycin.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/15192777